Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) EPS (Basic) (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed EPS (Basic) for 5 consecutive years, with -$0.16 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 65.22% to -$0.16 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.32 through Dec 2025, up 19.02% year-over-year, with the annual reading at -$1.32 for FY2025, 19.02% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.16 at Werewolf Therapeutics, up from -$0.36 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.95 in Q4 2021, with the low at -$83.36 in Q1 2021.
  • Average EPS (Basic) over 5 years is -$4.63, with a median of -$0.4 recorded in 2022.
  • The sharpest move saw EPS (Basic) skyrocketed 99.33% in 2022, then plummeted 185.71% in 2024.
  • Over 5 years, EPS (Basic) stood at $0.95 in 2021, then tumbled by 140.0% to -$0.38 in 2022, then grew by 13.16% to -$0.33 in 2023, then plummeted by 39.39% to -$0.46 in 2024, then soared by 65.22% to -$0.16 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.16, -$0.36, and -$0.4 for Q4 2025, Q3 2025, and Q2 2025 respectively.